Financials

  • Market Capitalization 467.21 M
  • Employee 17
  • Founded 2004
  • CEO N/A
  • Website www.relmada.com
  • Headquarter Nevada, United States
  • FIGI BBG003MKSL16
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.33
市销率
-2 407.45

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2950
PRTA
Prothena Corporation plc - Ordinary Shares
9.31 USD+2.42%-0.43%+7.75%+12.58%477.95 M USD
2959
PBYI
Puma Biotechnology Inc - Common Stock
9.09 USD-1.62%-0.44%+14.20%+80.72%469.23 M USD
2979
PRLD
Prelude Therapeutics Incorporated - Common Stock
5.71 USD-9.94%-14.14%+23.06%+342.64%455.68 M USD
2980
OCGN
Ocugen, Inc. - Common Stock
1.34 USD-2.19%-3.60%+7.20%+28.85%454.41 M USD

新闻